Despite a relatively short DSS administration period, WOL intervention improved the expression levels of cancer-related proteins in the colon (Anxa3 and Co3) as well as oncogenic hepatic genes (Saa1, Jun and S100a8) as observed in the DSSWOL mice as compared to the DSS group. The gene discussed is JUN; the disease is cancer.